XCures, a pioneering startup focused on enhancing patient data management through artificial intelligence, has successfully closed a $46 million Series B funding round, as reported exclusively by Crunchbase News. The round was led by Innovius Capital, with contributions from iGrow, Spring Mountain Capital, and existing investors, bringing the total funding to over $76 million since the company's inception in 2018. This latest financing values XCures at $127 million post-money, more than doubling its previous valuation following a $25 million Series A round concluded in December 2023. CEO Mika Newton emphasized the need for reliable systems to make healthcare data usable, noting the historical challenges posed by the disorganized nature of medical records. XCures aims to tackle this issue head-on by creating a 'clinical clarity engine' that transforms messy data into actionable insights for healthcare providers. The startup has already processed over 300 million medical records, supporting clinical decisions for millions of patients across the United States, and is on track to significantly increase its annual recurring revenue in the coming years.
Source: Crunchbase
